This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

WellCare Health Plans Implements MedAssurant's Star Advantage™ Solution









BOWIE, Md., Feb. 20, 2012 /PRNewswire/ -- MedAssurant, Inc., a leading provider of data-driven health care solutions, today announced that WellCare Health Plans, Inc. (NYSE: WCG), a leading provider of government-sponsored health care programs, has selected MedAssurant's Star Advantage™ and INDICES™ solutions for a multi-year engagement to provide an integrated capability to both better understand and meaningfully impact its CMS Five-Star Quality Ratings. The combined solution leverages the nation's most widely used health care quality measurement system, large-scale health care dataset analytics, and a nationwide clinical operations infrastructure to proactively identify, and both efficiently and effectively resolve gaps in member quality outcomes.

(Logo: http://photos.prnewswire.com/prnh/20120215/NE54014LOGO)

Star Advantage's predictive analytics are informed by MedAssurant's Medical Outcomes for Research on Economics and Effectiveness (MORE2) Registry™ which contains more than 5.2 billion medical events from more than 77 million unique de-identified individuals. Leveraging the unprecedented insight afforded by this comprehensive dataset, Star Advantage provides WellCare near-real-time insight to identify highly specific opportunities for quality improvement. An additional analytical layer is applied to determine ideal intervention modality, venue, content, and timing for optimal member and provider engagement and gap resolution success. MedAssurant's nationwide infrastructure of clinical call centers, message fulfillment, integrated data platforms, and in-market clinical personnel numbering in the thousands brings to bear an end-to-end capability from analysis to impact -- enabling meaningful quality outcomes improvement.

"WellCare is focused on leveraging innovative approaches that both improve our quality outcomes and help us enhance health and quality of life for our members," said Walter Cooper, Chief Administrative Officer of WellCare. "We are pleased with the opportunity to continue working with MedAssurant and are confident that the unique capabilities offered by the Star Advantage and INDICES solutions will play a key role in helping us achieve our service and quality goals."

"MedAssurant understands the importance of quality outcomes and the necessity for today's leading health care organizations to have detailed, timely insight into their CMS Five-Star Quality Ratings," said Keith Dunleavy, M.D., President and Chief Executive Officer of MedAssurant. "Even more critical, however, is to have visibility into the predictive progression of these quality ratings and the intervention capabilities to support the achievement of targeted goals. Throughout our relationship with WellCare, we have been very impressed by their attentive approach to best practices with both their members and providers. It is a pleasure to work with a partner that is so clearly and consistently dedicated to these values."

The MedAssurant and WellCare relationship dates back to 2008 when MedAssurant began coordinating clinical data accuracy and claims analytics solutions for WellCare's Medicare lines of business. In 2010, MedAssurant and WellCare expanded their relationship to add prospective analytical processes (known as Prospective Advantage™). With this expansion of the relationship, MedAssurant will now implement its Star Advantage and the INDICES solutions.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs